Verrica Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Verrica Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Verrica Pharmaceuticals Inc
Rating: 1.91000
Author: Trendlyne DVM scores

about

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered...

6.27 -0.68 (-9.78%)

36.15% Fall from 52W High

81,592

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Verrica Pharma Inc is on 19 May 2026 for the purpose of H.C. Wainwright 4th Annual BioConnect Investor Conference See details

Not Eligible

Expensive Valuation

18.0 / 100

Technically Neutral

58.4 / 100

1Yr Price target upside is 162%

4 analysts

Verrica Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Verrica Pharma Inc Live Stock Price Today, Share Analysis and Chart

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered...

36.15% Fall from 52W High

SWOT Analysis

Verrica Pharma Inc Live Price Chart